It is noteworthy that TGF-β/Smad, NF-κB, PI3K/AKT, Nrf2, AMPK, NLRP3, and Wnt/β-catenin signaling pathways are prominent in the above studies of TCM against DCM. The gene discussed is NFE2L2; the disease is familial dilated cardiomyopathy.